||1. Ikemoto M, et al., A useful ELISA system for human liver-type arginase, and its utility in diagnosis of liver diseases. Clin Biochem. 34, 455-461 (2001). 2. Ikemoto M, et al., Liver-type arginase in serum during and after liver transplantation: a novel index in monitoring conditions of the liver graft and its clinical significance. Clin Chim Acta. 271, 11-23 (1998). 3. Zimmermann N, et al., Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest. 111, 1863-1874 (2003). 4. Vercelli D: Arginase: marker, effector, or candidate gene for asthma? J Clin Invest. 111, 1815-1817 (2003). 5. Xu L, Hilliard B, et al., Arginase and immune inflammation in the central nervous system. Immunology. 110 , 141-148 (2003). 6. Roikhel VM, et al., Alterations of arginase activity in scrapie-infected mice and in amyotrophic lateral sclerosis. Acta Virol. 34, 545-553 (1990). 7. Ikemoto M, et al., Expression of human liver arginase in Escherichia coli. Purification and properties of the product. Biochem J. 270, 697-703 (1990). 8. Lavulo LT, et al., Subunit-subunit interactions in trimeric arginase. Generation of active monomers by mutation of a single amino acid. J Biol Chem. 276, 14242-14248. (2001). 9. Dillon BJ, et al., Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production. Med Sci Monit. 8, :BR248-253 (2002).